Biotech

All Articles

ArsenalBio increases $325M, turns far from former lead asset

.Collection Biosciences is actually carrying on up. The cell therapy firm has added $325 million in ...

Lilly- backed effective weight loss biotech files IPO

.After increasing $170 thousand back in February, metabolic disease-focused BioAge Labs has actually...

Aelis' marijuana make use of drug fails period 2b, driving Indivior to review $100M possibility

.Aelis Farma's chances of protecting an easy, positive selection on a $one hundred thousand possibil...

ProKidney halts phase 3 test not needed for tissue treatment authorization

.ProKidney has actually ceased among a pair of phase 3 trials for its own cell treatment for kidney ...

Vaxcyte surges on 'remarkable' 31-valent PCV win versus Pfizer

.Vaxcyte unveiled what professionals called "remarkable" phase 1/2 information for its 31-valent pne...

Recursion's mind health condition test presents scant proof of efficiency

.Recursion has actually discovered with a very early test of its tech-enabled strategy to medicine r...

Acepodia, Pfizer click with each other for chemistry-based cell treatment

.Phone it a case of good chemical make up: Acepodia, a biotech based on Nobel Prize-winning science,...

Praxis epilepsy medicine reduces confiscations in period 2 hearing

.Praxis Preciseness Medicines has scored one more midphase win in epilepsy this year, with its own s...

Three officers resign as Dyne posts blended records for DMD candidate

.After leaving a clinical grip many years back, Dyne Rehab has actually disclosed brand-new period 1...

Arrowhead fires off stage 3 data in rare metabolic health condition before market clash with Ionis

.Arrowhead Pharmaceuticals has revealed its hand in advance of a prospective face-off along with Ion...